The Postpartum Haemorrhage (PPH) Butterfly Work Package 3

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-01

Study Completion Date

2017-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Postpartum Haemorrhage (PPH) Butterfly is a simple, low-cost device which has been developed as a treatment method for PPH. It will be used to stop the bleeding through compression of the uterus of women having a PPH. It will be markedly easier to undertake than traditional bimanual compression, whilst also being significantly more acceptable to women themselves. Use of the PPH Butterfly will provide an alternative management option for PPH and in some cases should avoid the need for women to have to go to theatre for treatment. This research will allow the investigators to determine if they have the optimum size and shape of the device, that it will operate as intended when compressing the uterus, and to gauge its acceptability to participants and users. In phase I the investigators will recruit "healthy volunteers" i.e. women who have delivered their baby vaginally following Induction of labour (IOL) however these women will not be experiencing a PPH. The device is to be assessed purely on size, usability and acceptability not for diagnosis or as a treatment method. Following the delivery participants will be invited to have the PPH Butterfly inserted vaginally for an average of 2 minutes. It is through this that the investigators will assess the suitability of the device in its current design, when it is in practice. The clinician who operates the device will complete a Likert scale questionnaire along with some open questions following each administration. Participants will also answer a short questionnaire. .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage

NCT02883673

Postpartum Hemorrhage

COMPLETED NA

Uterine Tamponade for Treatment of Primary Postpartum Hemorrhage

NCT02568657

Postpartum Hemorrhage

COMPLETED NA

rhuFVIIa in Post-partum Hemorrhage

NCT00370877

Postpartum Hemorrhage

COMPLETED PHASE4

Physician Optimised Post-partum Hypertension Treatment Trial

NCT04273854

Pre-Eclampsia Gestational Hypertension

ACTIVE_NOT_RECRUITING NA

Vacuum Device for Hemostasis in Obstetrics and Gynecology

NCT02816203

Primary Postpartum Hemorrhage Administration of Sulprostone Vaginal Childbirth

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will involve 5-10 healthy women who deliver their baby vaginally following Induction of Labour (IOL). The women will be given a short leaflet regarding the study. During their time on the Induction of Labour (IOL) Suite, women will be seen by a member of the research team, the research will be discussed with them and they will receive a Participant Information Sheet if they desire. The woman will also be shown a short video regarding the Postpartum Haemorrhage (PPH)Butterfly which is specifically for members of the public. After a discussion of the research, women will be asked to indicate in writing whether they may consider participation, whether they do not want to participate, or whether they are undecided but are happy to be asked again. Only those women who are considering participation, or who are happy to be asked again will be approached post-delivery. All of the women can be approached up to 72 hours post-delivery and asked if they wish to participate. If a woman has a vaginal delivery, a member of the research team will then attend the Delivery Suite, maternity theatre (the woman may have had an instrumental delivery in theatre) or the postnatal ward once informed by the midwife caring for her. They will clarify with the woman if she wishes to participate. Assuming the woman wishes to participate, informed, signed consent will be sought at this point and the device will be used, with a speculum examination taking place before and after use of the device.

If the device is of an incorrect size, then the device size will be changed before repeating the process with 5-10 more women. In this way the final recruitment number may be more than 10 in total.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Haemorrhage (PPH)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

If the device is not of the correct size, then the device is changed and the recruitment process is repeated until the correct size is obtained.

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Use of the PPH Butterfly

The PPH Butterfly will be inserted into the vagina of a healthy postnatal woman

Group Type OTHER

The PPH Butterfly

Intervention Type DEVICE

The PPH Butterfly is a simple, low cost device that has been developed to facilitate less invasive compression of the uterus in a PPH

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The PPH Butterfly

The PPH Butterfly is a simple, low cost device that has been developed to facilitate less invasive compression of the uterus in a PPH

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who have a vaginal delivery following induction of labour and who are within 72 hours of delivery.

Exclusion Criteria

* Women assessed antenatally to have learning difficulties that may have the potential to impair their decision making
* Women aged \< 16 years of age
* Women who cannot read or understand the level of English used in the study documentation
* Women who've had a stillbirth (in this pregnancy)
* Women who have undergone Female Genital Mutilation/vaginal surgery which is unreversed (assessed antenatally)
* Women with clotting disorders; either longstanding or following intrapartum events
* Women who have just had, or are having an ongoing PPH
* Women in whom the third stage of labour is not complete (placenta remains in situ).
* Women who have had a caesarean section

Minimum Eligible Age

16 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes